Anne-Marie Koop

322 84. Jensen MK, Bertoia ML, Cahill LE, Agarwal I, Rimm EB, Mukamal KJ. Novel metabolic biomarkers of cardiovascular disease. Nat Rev Endocrinol Nature Publishing Group; 2014;10:659–672. 85. Calvier L, Legchenko E, GrimmL, Sallmon H, HatchA, Plouffe BD, Schroeder C, Bauersachs J, Murthy SK, Hansmann G. Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension. Heart 2016;102:390–396. 86. Tang WHW, Brennan ML, Philip K, Tong W, Mann S, Lente F Van, Hazen SL. Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure. Am J Cardiol 2006;98: 796–799. 87. Besler C, Lang D, Urban D, Rommel KP, Roeder M Von, Fengler K, Blazek S, Kandolf R, Klingel K, Thiele H, Linke A, Schuler G, Adams V, Lurz P. Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: Implications for its use as a biomarker. Circ Hear Fail 2017;10:1–9. 88. Kempf T, Haehling S von, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure. J Am Coll Car diol 2007;50:1054–1060. 89. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AHB, Richards M, Clopton P, Filippatos GS, Somma S Di, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, Haehling S von, Bergmann A, Morgenthaler NG, Anker SD. Mid-Region Pro- Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea. Results From the BACH (Biomarkers in Acute Heart Failure) Trial. J Am Coll Cardiol Elsevier Inc.; 2010;55:2062–2076. 90. Tromp J, Khan MAF, Mentz RJ, O’Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Veldhuisen DJ Van, Hillege HL, Voors AA, Meer P van der. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC Hear Fail 2017;5:507–517.